The Nelson Memo: Igniting a Global Open Data Revolution
The landscape of scientific research is undergoing a seismic shift, driven by an urgent demand for transparency, reproducibility, and equitable access. At the epicenter of this transformation in the United States is the Nelson Memo, a policy directive rapidly accelerating the future of open science. With the National Institutes of Health (NIH)'s recent announcement (NOT-OD-25-101)…...
Read MoreTop Stories
MAPS 2025 Decoded: The Medical Affairs Playbook
At the MAPS Americas 2025 conference in New Orleans, one of...
Medical Affairs 2.0: GenAI as the Catalyst for
Digital and AI were hot topics underpinning many of the...
The Paradigm Shift from Traditional Scientific
In the rapidly evolving biopharma landscape, the approach to...
Filter
Which Regulatory Requirements Are Applicable to “Legacy” Devices?
Understanding the requirements for your medical device is vital in today’s market. But are these...
Ensuring Alignment Across EU MDR Deliverables
How to avoid all these pitfalls and keep thriving in the EU Medical Devices market?...
Medical Information in the Digital Age – Quick and Efficient Meets Responsive and Responsible
Medical Information (MI teams across the pharmaceutical industry respond to product-related medical queries from HCPs...
HEOR in 2022: The Importance of Data Visualization, RWD, and Interactive Formats
Effectively communicating data in the pharmaceutical and medical community is vital to payer engagement. Learn...
Bite-Sized Content Helps Avoid User Fatigue – How Can Pharma Use It?
Today's readers tend to avoid long pharma content and medical jargon. If you want to...
What Makes Stakeholders Trust Pharma-Generated Scientific Content and How Can the Industry Do Better?
While diverse pharma stakeholders are now consuming scientific content digitally more than ever before, the...